Table 3.
Baseline to follow-up changes in blood pressure by the baseline blood pressure category from among participants with complete data.
| Parameters | Participants, n | Baseline value, mm Hg | Follow-up value, mm Hg | Difference, mm Hg | t test (df) | 95% CI | P value |
|
|||||||||||
| Home range |
|
||||||||||||||||||
|
|
Systolic blood pressure |
|
|||||||||||||||||
|
|
|
Blood pressure at goal | 26 | 122.0 | 122.0 | 0.0 | 0.0 (25) | –3.4 to 3.4 | 1.00 | ||||||||||
|
|
|
Stage 1 hypertension | 19 | 130.0 | 126.0 | –3.6 | –1.8 (18) | –7.8 to 0.6 | .09 | ||||||||||
|
|
|
Stage 2 hypertension | 76 | 145.0 | 135.0 | –10.3 | –6.5 (75) | –13.4 to –7.1 | <.001 | ||||||||||
|
|
Diastolic blood pressure | ||||||||||||||||||
|
|
|
Blood pressure at goal | 26 | 74.0 | 73.0 | –1.1 | –0.9 (25) | –3.7 to 1.5 | .40 | ||||||||||
|
|
|
Stage 1 hypertension | 19 | 79.0 | 76.4 | –2.6 | –2.4 (18) | –4.9 to –0.3 | .03 | ||||||||||
|
|
|
Stage 2 hypertension | 76 | 88.4 | 81.9 | –6.5 | –6.1 (75) | –8.6 to –4.4 | <.001 | ||||||||||
| Office range |
|
||||||||||||||||||
|
|
Systolic blood pressure | ||||||||||||||||||
|
|
|
Blood pressure at goal | 26 | 122.0 | 122.0 | 0.0 | 0.0 (25) | –3.4 to 3.4 | 1.00 | ||||||||||
|
|
|
Stage 1 hypertension | 39 | 133.0 | 130.0 | –2.5 | –1.7 (38) | –5.4 to 0.5 | .10 | ||||||||||
|
|
|
Stage 2 hypertension | 56 | 148.0 | 135.0 | –13.4 | –7.3 (55) | –17.1 to –9.7 | <.001 | ||||||||||
|
|
Diastolic blood pressure | ||||||||||||||||||
|
|
|
Blood pressure at goal | 26 | 74.0 | 73.0 | –1.1 | –0.9 (25) | –3.7 to 1.5 | .40 | ||||||||||
|
|
|
Stage 1 hypertension | 39 | 81.4 | 78.5 | –2.9 | –3.1 (38) | –4.8 to –0.98 | .004 | ||||||||||
|
|
|
Stage 2 hypertension | 56 | 90.1 | 82.4 | –7.7 | –5.8 (55) | –10.4 to –5.1 | <.001 | ||||||||||